Tag Archives: Conference

CNA2020

New partnerships mean more medical isotope production

Image of Westinghouse and Nordion executives signing a letter of intent.
Westinghouse and Nordion signed a letter of intent to develop innovative isotope production technology that will allow cobalt-60 to be produced in pressurized water reactors.

According to the Canadian Nuclear Isotope Council, the global isotope market was estimated to be US$9.6 billion. It is projected to grow to more than US$17.1 billion by 2023. Canada’s position in that market recently got stronger with two new partnership agreements.

Framatome and Kinectrics Launch Joint Venture to Produce Medical Isotopes for Lifesaving Cancer Treatment

At CNA2020 on Feb. 28, Framatome and Kinectrics announced the launch of Isogen. The joint venture will provide and support isotope production systems for Bruce Power’s nuclear reactors to begin the production of lutetium-177.

Lutetium-177 is used as a gamma emitter for imaging. It is also a beta emitter used for targeted radiotherapy for the treatment of a growing number of cancers, including prostate cancer, neuroendocrine tumours and bone metastases.

“We are proud to have established a new Ontario-based company, Isogen, with our partner, Framatome,” said David Harris, Kinectrics president and CEO. “Together, we will work with Bruce Power to produce life-saving medical isotopes, specifically lutetium-177, which will help to advance the global fight against cancer.”

“Partnering with Kinectrics to launch Isogen marks our commitment to advance isotope development as we continue to work with the team at Bruce Power in the fight against cancer,” said Bernard Fontana, CEO at Framatome. “Together, we are working with Bruce Power to maximize existing infrastructure, already known for producing reliable, low-carbon electricity, and making important, life-saving medical treatments available to patients around the world.”

The partnership will leverage the scale, redundancy and longevity of the eight-unit facility to anchor a new, global supply of isotopes. Following regulatory and other approvals, the plan is to begin isotope production in 2022. The goal is to allow scaling based on demands for lutetium-177 and other isotopes.

“As home to Ontario’s largest private-sector infrastructure project, we are not only extending our assets to provide low-cost, clean electricity for our families and business but are also ensuring that we are playing a leadership role in providing the global health community with access to isotopes that are critical to a modern health-care system and in the fight against cancer,” said Michael Rencheck, president and CEO of Bruce Power.

Westinghouse Partners with Nordion to Increase Future Supply of Life-Saving Cobalt-60

Two days before the Isogen announcement, Westinghouse Electric Company and Nordion (Canada) Inc. announced they signed a letter of intent to develop innovative isotope production technology that will allow cobalt-60 to be produced in pressurized water reactors (PWRs).

Cobalt-60 is the most common radioisotope used in radiation therapy. Hospitals also use cobalt-60 to sterilize medical equipment, such as gowns, gloves, masks, syringes and implants.

“Westinghouse, a leader in nuclear technology throughout the world, brings a strong set of operational experience, engineering skills and a robust safety culture to this collaboration. We look forward to contributing to the health and well-being of people around the world,” said Patrick Fragman, president and CEO of Westinghouse.

“This partnership will substantially expand future supply options for life-saving cobalt-60,” said Kevin Brooks, president of Nordion, a leading supplier of cobalt-60 globally. “Cobalt-60 is critical to our mission of Safeguarding Global Health, and we continue to invest heavily in maintaining a reliable, long-term supply.”

According to the World Nuclear Association, almost all the world’s supply of the radioisotope is produced in Candu reactors, mostly in Canada.

Expanding production to PWRs — of which there are nearly 100 in North America alone — will strengthen the diversity of the global supply chain.

CNA2020

ONE LUNCH WITH TWO GUEST SPEAKERS

After enjoying a delicious lunch on Thursday, CNA2020 delegates will be treated to not one but two keynote speakers.

Portrait of Laurie SwamiLaurie Swami is the President and CEO of the Nuclear Waste Management Association. Appointed in 2016, she is responsible for implementing Canada’s plan for the long-term management of used nuclear fuel.

Swami previously served as Senior Vice-President of Decommissioning and Nuclear Waste Management at Ontario Power Generation (OPG). She oversaw the operation of OPG’s nuclear waste management facilities. Swami was responsible for strategic projects, such as OPG’s low- and intermediate-level waste deep geologic repository, Pickering Nuclear Generating Station’s Safe Storage project and Post Pickering End of Commercial Operations strategy. She began her career at OPG in 1986.

Portrait of John GormanJohn Gorman is the President and CEO of the Canadian Nuclear Association. Appointed in 2019, he oversees all the organization’s activities, including government affairs, research, communications and industry leadership.

Previously Gorman was the President and CEO of the Canadian Solar Industries Association, the national trade association for Canada’s solar energy industries. Before that, he was the Senior-Vice President of Empower Energies, an innovative, global integrator of energy systems.

Gorman serves as Canada’s Designate to the International Energy Agency and sits on the Executive Council of the Canadian Council on Renewable Energy. He has served as a director on the boards of numerous community and corporate organizations, including one of the nation’s largest electric utilities.

If you’re attending CNA2020, join them for lunch on Thursday, February 27 from 12:00 to 14:00.

To see the full conference schedule, visit https://cna.ca/cna2020/program/.

CNA2020 Uncategorized

Provincial perspectives on small modular reactors

Two provincial cabinet members will take the CNA2020 mainstage to offer their perspectives of small modular reactors (SMRs) in their respective provinces.

Portrait of Dustin DuncanDustin Duncan has been the member of the Saskatchewan Legislative Assembly for Weyburn-Big Muddy since 2006. A member of the Saskatchewan Party, he currently serves as the Minister of Environment, Minister responsible for SaskPower and Minister responsible for the Water Security Agency. Previously, he managed various portfolios, including Energy and Resources, SaskEnergy.

Portrait of Greg RickfordIn 2018, Greg Rickford was elected as the member of Ontario Legislature for Kenora—Rainy River. A member of the Progressive Conservative Party, he is the Ministry of Energy, Northern Development and Mines and the Minister of Indigenous Affairs. Previously, Rickford was the member of Parliament for the riding of Kenora since 2008. Federally, he served as Minister of State (Science and Technology, and Federal Economic Development Initiative for Northern Ontario), Minister of Natural Resources and other portfolios.

In December, the premiers of Saskatchewan, Ontario and New Brunswick signed a memorandum of understanding (MOU) to advance the development and deployment of SMRs. To address climate change, regional energy demand and economic development, the MOU commits the provinces to work cooperatively to:

  • address key issues for SMR deployment, such as technological readiness, regulatory frameworks, financing, waste management, and public and Indigenous engagement;
  • develop support for the SMR Roadmap and as requested by the CEOs of SaskPower, Ontario Power Generation, Bruce Power and NB Power;
  • work with all levels of government to promote nuclear as clean energy;
  • influence the federal government to make the necessary changes to facilitate the introduction of SMRs;
  • engage with other interested provinces and territories to explore the potential for SMR deployment in their jurisdictions; and
  • inform the public about the economic and environmental benefits of nuclear energy and SMRs.

Join this CNA2020 plenary session on Thursday, February 27 from 11:00 to 12:00.

Find the complete CNA2020 schedule at https://cna.ca/cna2020/program/.

CNA2020

Get the most out of CNA2020: Download the app!

CNA2020 QR codeGet CNA2020 details at your fingertips with our event app. There are two ways to download the Event Buddy by Pheedloop:

  • from iTunes or the Google Store,
  • by using the QR code shown here.

Screen shot of the CNA2020 mobile appOpen the app and use the code CNA2020 to view conference details.

View the detailed program, read speaker biographies, navigate the floor plan, live tweet and more! Log-in to personalize your schedule, connect with attendees and play the scavenger hunt and networking games in our mobile app! There are two opportunities to win:

  1. Be in the top 10, Thursday, February 27 at 18:00 and be entered in a draw to win wireless, noise-cancelling headphones. You must be in attendance to win.
  2. On Friday, February 28 at 11:30, be the top point earner on the game leaderboard and you win a Garmin Vivo Smart HR watch.

And don’t forget, if you need Wi-Fi access, use the network cna2020 with the password cna2020.

CNA2020

NUCLEAR IN SCIENCE AND MEDICINE

In the century or so since the start of nuclear science, we’ve made many useful discoveries. Nuclear medicine covers diagnosing diseases, treating patients with cancer and sterilizing gowns, gloves, masks, syringes and implants. What are the next exciting frontiers? Find out during a panel presentation on February 28 from 10:30 to 11:30 at CNA2020.

As the Technical and Business Director for Medical Isotopes at Kinectrics, Travis Besanger is responsible for building a strong value chain for Kinectrics’s products and for establishing a state-of-the-art isotope processing centre at the company’s Teeswater, Ontario, location. Before joining Kinectrics in 2019, he had 13 years of experience in the radiopharmaceutical industry. Most of that was at the Centre for Probe Development and Commercialization, where he led commercialization of radiopharmaceuticals and medical isotope products.

Image of Thomas R. Burnett is Vice-President and General Manager of BWXT Isotope Technology Group (ITG) Canada. He is responsible for all aspects in the establishment and direction of the BWXT ITG Canada operation. Before joining BWXT in 2017, Burnett had varying levels of responsibility in the nuclear medicine industry related to marketing. He has worked in sales, general management and consulting at Nordion, Thermo Fisher Scientific, Ernst & Young and Merck Frosst.

Image of Karen MossmanKaren Mossman is the Associate Vice-President of Research at McMaster University. Mossman joined McMaster in 2001 with a research focus on understanding the interactions between viruses and their hosts, both in normal healthy cells and in cancer cells. The Department of Pathology and Molecular Medicine Professor’s goal is to develop novel therapy approaches for emerging viral infections and cancer. She also serves as Chair of the Board of the McMaster Innovation Park.

Find the complete CNA2020 schedule at https://cna.ca/cna2020/program/.

To register for the conference, visit https://cna.ca/cna2020/registration/.

CNA2020

CNA2020 Sponsor Spotlight: Canadian Nuclear Safety Commission

The Canadian Nuclear Association is proud to shine a spotlight on each of its CNA2020 Gold-level sponsors, which includes the Canadian Nuclear Safety Commission (CNSC).

The CNSC was established in 2000 under the Nuclear Safety and Control Act. It reports to Parliament through the Minister of Natural Resources. The CNSC replaced the Atomic Energy Control Board (AECB), which was founded in 1946.

The CNSC regulates the development, production, possession, use and transportation of nuclear energy, materials and equipment to protect health, safety, security and the environment. It enforces Canada’s international commitments to control the development, production, transportation and use of nuclear energy and materials, including measures related to the non-proliferation of nuclear weapons. The CNSC’s mandate is also to share objective scientific, technical and regulatory information to the public about its activities and on the effects on the environment; on the health and safety of people; and on the development, production, possession, transport and use of nuclear substances.

The CNSC makes independent, fair and transparent decisions on licensing nuclear-related activities. The commission has up to seven appointed permanent members. Their decisions are supported by more than 800 employees. They are a diverse team of highly skilled nuclear professionals, including scientists, engineers, corporate professionals, new graduates and students. These employees review applications for licences according to regulatory requirements, make recommendations to the commission, and enforce compliance with the Nuclear Safety and Control Act, regulations and any licence conditions imposed by the commission.

At CNA2020, you can find the CNSC at Booth 108.

You can still register for the conference at https://cna.ca/cna2020/registration/.